Urology Flashcards
How might prostate cancer present itself?
2 week wait referral Abnormal DRE Bone pain Renal failure Weight loss
What do you give with an LHRH agonist to prevent tumour flares?
Anti-androgen
Most common site of prostate mets
Bone
Most common site of prostate mets
Bone
Bladder cancer investigation
Flexible cystoscopy
+ dip/MSU, urine cytology
+ pelvic MRI for local spread and CT for distant mets
Haematuria imaging?
U&E (to check if renal function is okay for contrast)
CTIVU (ureteric cancer)
Flexible cystoscopy
2 week wait referral indications for haematuria
> 45 and:
Unexplained visible haematuria in absence of UTI
Persistant visible haematuria following successful UTI treatment
> 60 and non-visible haematuria with dysuria or raised WCC
Consider non-urgent referral if >60 and recurrent UTIs
Prostate cancer DRE findings
Enlarged, hard, nodular, asymmetrical
When would you carry out a DRE on a patient
LUTS Haematuria Raised PSA ED Unexplained symptoms (e.g. weight loss, back pain, bone pain)
What must be avoided before a PSA test
Ejaculation or vigorous exercise in last 48 hours
Urological intervention in last 6 weeks
UTI in last 6 weeks
First line investigation of prostate cancer and what scoring system is used for this imaging of prostate cancer
Multiparametric MRI
Likert scoring (5 point)
When to do a prostate biopsy?
Likert score 3 and over
Low risk prostate cancer criteria
PSA <10NG/ML AND <6 Gleason AND T1-T2A
High risk prostate cancer criteria
PSA >20NG/ML or 8-2 Gleason or >T2c
Management of localised prostate cancer
Active surveillance (only in low or intermediate risk), radical prostatectomy or radical radiotherapy
Management of metastatic prostate cancer
Docetaxel chemotherapy and androgen deprivation therapy
Most common cause of scrotal swelling, diagnosis and management
Epididymal cyst
Ultrasound
Usually supportive, or sclerotherapy or surgical removal if large
Characteristics of acute urinary retention
Painful
600ml-L
normal U&Es
Relieved by catheter
Management of acute urinary retention
Catheter Alpha blocker (tamsulosin) for TWOC)
Chronic urinary retention characteristics
Impaired renal function and hydronephrosis (if high pressure)
Painless
Risk of stones and infection
Management of non-muscle-invasive bladder cancer
TURBT (trans urethra removal of bladder tumour)
Intermediate risk: + intravesical mitomysin C
High risk: + repeat TURBT after 6 weeks + intravesical BCG or radical cystectomy
Radical cystectomy given with cisplatin
Management of muscle-invasive bladder cancer
Radical cystectomy or radiotherapy
Neoadjuvant cisplatin given before cystectomy
Management of epididymo-orchitis
IM ceftriaxone + ora doxycycline
What is Prehn’s sign and what is it suggestive of
Testicular pain that eases on elevation of the teste
Suggests epidiymo-orchitis as relieves the pressure on epididymis
Presentation and management of testicular torsion
Sudden severe pain in testicle often referred to lower abdomen
Nausea and vomiting
Swollen, red and elevated teste
Prehn’s sign absent
Loss of cremasteric reflex
Mx: surgical fixation of both testes
Causes and symptoms of urethral stricture
STIs
Hypospadias
Lichen sclerosis
Traumatic placement of catheter
Sx: painful/difficulty urinating, dribbling, incomplete emptying
Why can chemotherapy increase risk of renal stones?
Increases uric acid
Most common type of renal stones?
Calcium oxalate
What renal stones are associated with chronic infection?
Struvite - staghorn stones
Result of urease producing bacteria (proteus mirabilis)
Characteristics of testicular cancer
Painless lump
Raised LDH, AFP and hCG (in non-seminomas) can be seen
Gynaecomastia
Types of testicular cancer
Seminomas
Non-seminomas (teratoma, embryonal, yolk sac)
Risk factors associated with testicular cancer
Cryptorchidism
Infertility
Kleinfelters
Fhx
Diagnosis and management of testicular cancer
Ultrasound
Orchidectomy
Chemo/radio
Renal cell carcinoma triad and other features
Flank pain
Haematuria
Renal mass
Left varicocele (occlusion of left testicular vein)
Eryhtropoeitin production (polycythaemia)
PTH (hypercalcaemia), renin, ACTH
Paraneoplastic hepatic dysfunction syndrome (Stauffer) with hepatosplenomegaly and cholestasis
Management of renal cell carcinoma
Partial/total nephrectomy
Alpha-interferon and IL-2 (if mets or to reduce tumour size)
Sunitinib (receptor tyrosine kinase inhibitor)
Infection associated with squamous cell carcinoma of the bladder
Schistostomiasis (African)
Management of metastatic prostate cancer
HORMONAL THERAPY GnRH agonists (goserelin)
+ anti-androgen (cyproterone acetate or flutamide) to prevent rise in testosterone
Orchidectomy